from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0945/-

LFCtreatmentdescriptionclass of inhibitor

0.117

Amikacinug/mL Amikacintranslation

-0.721

Cap5-10ug/mL Capreomycintranslation

-0.025

Rox10-50 ug/mL Roxithromycintranslation

-0.099

SM2-5 ug/mL Streptomycintranslation

0.918

Tet5-10 ug/mL Tetracyclinetranslation

0.776

Rif0.2-5ug/mL Rifampicintranscription

0.276

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.191

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.771

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.243

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.498

Clofazimine10-13 ug/mL Clofaziminerespiration

0.167

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.313

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.052

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.078

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.208

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.388

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.091

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.807

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.386

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.500

KCN5-20 ug/mL Potassium cyaniderespiration

0.262

NaN30.2-2 mM Sodium aziderespiration

-0.767

Nigericin50 uM Nigericinrespiration

0.338

TRC10-150 ug/mL Triclosanrespiration

-1.077

TRZ10-25 ug/mL Thioridazinerespiration

-1.030

Valinomycin0.5-10 uM Valinomycinrespiration

-1.762

ZnSO42 mM ZnSO4respiration

0.426

menadione6-10 ug/mL Menadionerespiration

-0.260

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.654

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.852

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.624

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.580

NRP_1Non-replicating persistence stage 1dosRassociated

-0.596

Amp0.2mg/mL AmpicillincellWall

-0.469

Cephalexin20-100 ug/mL CephalexincellWall

-0.607

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.432

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.629

EMB10-20 ug/mL EthambutolcellWall

-0.624

Eta12-40 ug/mL EthionamidecellWall

-0.771

INH0.2-0.4 ug/mL IsoniazidcellWall

0.012

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.887

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.877

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.455

BZA0.12 mg/mL BenzamidearomaticAmides

0.643

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.948

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.459

H2O24 mM hydrogen peroxideDNAdamaging

0.283

Levo10 ug/mL LevofloxacinDNAdamaging

-0.019

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.542

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.044

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.262

UVUV-irradiationDNAdamaging

0.618

ARP41-4 ug/mL Antitubercular compound ARP4?

0.272

Antimycin12.5-50 ug/mL Antimycin A?

-0.525

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.217

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.187

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.091

PA8240.2-2 ug/mL PA-824?

0.756

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.308

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.375

Verapamil50 uM Verapamil?

1.104

mercaptoethanol2 mM 2-Mercaptoethanol?

0.035

methoxatin10-20 ug/mL Methoxatin?